CRL

314.3104.15%
BG

Birgit Girshick

CEO & Director

Ms. Birgit Girshick is CEO and Director at Charles River Laboratories International, Inc. since May 05, 2026. She served as Chief Operating Officer at Charles River Laboratories International, Inc. since November 11, 2021 until May 05, 2026 and served as its Corporate Executive Vice President since 2021 until May 05, 2026. She served as Corporate Executive Vice President of Discovery, Safety Assessment and Biologics Solutions at Charles River Laboratories International, Inc. since 2021 until November 11, 2021 and had been its Corporate Executive Vice President of Global Discovery and Safety Assessment, Biologics Testing Solutions and Avian Vaccine Services since February 2018 until 2021 and served as its Corporate Senior Vice President of Global Discovery Services at Charles River Laboratories International, Inc. since April 19, 2017. In 2016, Ms. Girshick served as Corporate Senior Vice President, Global Discovery Services. She served as Corporate Senior Vice President of Research Models & Biologics Testing Solutions at Charles River Laboratories International, Inc. since October 2013 until April 19, 2017. Ms. Girshick is responsible for identifying growth opportunities and managing operations for the North American Research Models and Global Biologics businesses. She joined Charles River in 1989 and held positions of increasing responsibility in RMS Germany and RMS Avian Vaccine Services businesses. She served as General Manager of the RMS Avian Vaccine Services business at Charles River Laboratories International, Inc. since 2004 and served as its Executive Director of RMS Process Improvement since 2009 and Corporate Vice President of Global Biopharmaceutical Services since 2010. Ms. Girshick received an M.B.A. degree from the University of Rhode Island and a B.A. degree from Eastern Connecticut State University.

Positions